Clin Colon Rectal Surg 2019; 32(01): 025-032
DOI: 10.1055/s-0038-1673351
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Surgical Care and Outcomes Assessment Program (SCOAP): A Nuanced, Flexible Platform for Colorectal Surgical Research

Vlad V. Simianu
1   Colorectal Surgery Program, Virginia Mason Medical Center, Seattle, Washington
Anjali S. Kumar
2   Elson S. Floyd College of Medicine, Washington State University, Everett, Spokane, Tri-Cities, and Vancouver, Washington
› Author Affiliations
Further Information

Publication History

Publication Date:
08 January 2019 (online)


The Surgical Care and Outcomes Assessment Program (SCOAP) is a surgeon-led quality improvement (QI) initiative developed in Washington State to track and reduce variability in surgical care. It has developed into a collaboration of over two-thirds of the hospitals in the state, who share data and receive regular benchmarking reports. Data are abstracted at each site by trained abstractors. While there has some overlap with other national QI databases, the data captured by SCOAP has clinical nuances that make it pragmatic for studying surgical care. We review the unique properties of SCOAP and offer some examples of its novel applications.

  • References

  • 1 Chen F, Shivarani S, Yoo J. Current status of quality measurement in colon and rectal surgery. Clin Colon Rectal Surg 2014; 27 (01) 10-13
  • 2 Flum DR, Fisher N, Thompson J, Marcus-Smith M, Florence M, Pellegrini CA. Washington State's approach to variability in surgical processes/outcomes: Surgical Clinical Outcomes Assessment Program (SCOAP). Surgery 2005; 138 (05) 821-828
  • 3 Wheeler JM, Gilbert JM. Controlled intraoperative water testing of left-sided colorectal anastomoses: are ileostomies avoidable?. Ann R Coll Surg Engl 1999; 81 (02) 105-108
  • 4 Schmidt O, Merkel S, Hohenberger W. Anastomotic leakage after low rectal stapler anastomosis: significance of intraoperative anastomotic testing. Eur J Surg Oncol 2003; 29 (03) 239-243
  • 5 Ricciardi R, Roberts PL, Marcello PW, Hall JF, Read TE, Schoetz DJ. Anastomotic leak testing after colorectal resection: what are the data?. Arch Surg 2009; 144 (05) 407-411 , discussion 411–412
  • 6 Kwon S, Morris A, Billingham R. , et al; Surgical Care and Outcomes Assessment Program (SCOAP) Collaborative. Routine leak testing in colorectal surgery in the Surgical Care and Outcomes Assessment Program. Arch Surg 2012; 147 (04) 345-351
  • 7 Feingold D, Steele SR, Lee S. , et al. Practice parameters for the treatment of sigmoid diverticulitis. Dis Colon Rectum 2014; 57 (03) 284-294
  • 8 Simianu VV, Basu A, Alfonso-Cristancho R, Thirlby RC, Flaxman AD, Flum DR. Assessing surgeon behavior change after anastomotic leak in colorectal surgery. J Surg Res 2016; 205 (02) 378-383
  • 9 Simianu VV, Bastawrous AL, Billingham RP. , et al. Addressing the appropriateness of elective colon resection for diverticulitis: a report from the SCOAP CERTAIN collaborative. Ann Surg 2014; 260 (03) 533-538 , discussion 538–539
  • 10 Rafferty J, Shellito P, Hyman NH, Buie WD. ; Standards Committee of American Society of Colon and Rectal Surgeons. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006; 49 (07) 939-944
  • 11 Klarenbeek BR, Samuels M, van der Wal MA, van der Peet DL, Meijerink WJ, Cuesta MA. Indications for elective sigmoid resection in diverticular disease. Ann Surg 2010; 251 (04) 670-674
  • 12 Kwon S, Florence M, Grigas P. , et al; SCOAP Collaborative, Writing Group for the SCOAP Collaborative. Creating a learning healthcare system in surgery: Washington State's Surgical Care and Outcomes Assessment Program (SCOAP) at 5 years. Surgery 2012; 151 (02) 146-152
  • 13 Colorectal Writing Group for the SCOAP-CERTAIN Collaborative. The impact of delaying elective resection of diverticulitis on laparoscopic conversion rate. Am J Surg 2015; 209 (05) 913-918 , discussion 918–919
  • 14 Bergqvist D, Agnelli G, Cohen AT. , et al; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346 (13) 975-980
  • 15 Sweetland S, Green J, Liu B. , et al; Million Women Study collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009; 339: b4583
  • 16 Vedovati MC, Becattini C, Rondelli F. , et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg 2014; 259 (04) 665-669
  • 17 Nelson DW, Simianu VV, Bastawrous AL. , et al; Colorectal Writing Group for Surgical Care and Outcomes Assessment Program–Comparative Effectiveness Research Translation Network (SCOAP-CERTAIN) Collaborative. Thromboembolic complications and prophylaxis patterns in colorectal surgery. JAMA Surg 2015; 150 (08) 712-720
  • 18 Ehlers AP, Simianu VV, Bastawrous AL. , et al; Colorectal Writing Group for the SCOAP-CERTAIN Collaborative. Alvimopan use, outcomes, and costs: a report from the Surgical Care and Outcomes Assessment Program Comparative Effectiveness Research Translation Network Collaborative. J Am Coll Surg 2016; 222 (05) 870-877
  • 19 Wolff BG, Michelassi F, Gerkin TM. , et al; Alvimopan Postoperative Ileus Study Group. Alvimopan, a novel, peripherally acting μ opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 2004; 240 (04) 728-734 , discussion 734–735
  • 20 Delaney CP, Weese JL, Hyman NH. , et al; Alvimopan Postoperative Ileus Study Group. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum 2005; 48 (06) 1114-1125 , discussion 1125–1126, author reply 1127–1129
  • 21 Ludwig K, Enker WE, Delaney CP. , et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg 2008; 143 (11) 1098-1105
  • 22 Delaney CP, Wolff BG, Viscusi ER. , et al. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg 2007; 245 (03) 355-363
  • 23 Bell TJ, Poston SA, Kraft MD, Senagore AJ, Delaney CP, Techner L. Economic analysis of alvimopan in North American Phase III efficacy trials. Am J Health Syst Pharm 2009; 66 (15) 1362-1368
  • 24 Holte K, Andersen J, Jakobsen DH, Kehlet H. Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery. Br J Surg 2009; 96 (06) 650-654
  • 25 Gorissen KJ, Benning D, Berghmans T. , et al. Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery. Br J Surg 2012; 99 (05) 721-727
  • 26 Hakkarainen TW, Steele SR, Bastaworous A. , et al. Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure: a report from Washington State's Surgical Care and Outcomes Assessment Program (SCOAP). JAMA Surg 2015; 150 (03) 223-228
  • 27 Devine EB, Alfonso-Cristancho R, Devlin A. , et al; CERTAIN Collaborative. A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network. J Clin Epidemiol 2013; 66 (8, Suppl): S122-S129
  • 28 Devine EB, Capurro D, van Eaton E. , et al. Preparing electronic clinical data for quality improvement and comparative effectiveness research: The SCOAP CERTAIN Automation and Validation Project. EGEMS (Wash DC) 2013; 1 (01) 1025